In the last trading session, 1.04 million shares of the Applied Therapeutics Inc (NASDAQ:APLT) were traded, and its beta was 2.03. Most recently the company’s share price was $7.70, and it changed around $0.0 or 0.00% from the last close, which brings the market valuation of the company to $884.34M. APLT currently trades at a discount to its 52-week high of $9.39, offering almost -21.95% off that amount. The share price’s 52-week low was $1.79, which indicates that the current value has risen by an impressive 76.75% since then. We note from Applied Therapeutics Inc’s average daily trading volume that its 10-day average is 2.61 million shares, with the 3-month average coming to 2.35 million.
Applied Therapeutics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.17. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 0 recommended APLT as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Applied Therapeutics Inc is expected to report earnings per share of -0.16 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Applied Therapeutics Inc (NASDAQ:APLT) trade information
The performance over the last five days has remained in the red territory. The rise to weekly highs of 8.63 on recent trading dayincreased the stock’s daily price by 10.78%. The company’s shares are currently up 129.85% year-to-date, but still down -9.41% over the last five days. On the other hand, Applied Therapeutics Inc (NASDAQ:APLT) is 35.09% up in the 30-day period. We can see from the shorts that 10.82 million shares have been sold at a short interest cover period of 10.18 day(s).
Applied Therapeutics Inc (APLT) estimates and forecasts
Applied Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 36.04 percent over the past six months and at a 40.85% annual growth rate that is well above the industry average of 17.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 66.00% in revenue this quarter, and will report an increase of 55.90% in the next quarter. The year-over-year growth rate is expected to be -83.00%, down from the previous year.
4 analysts expect Applied Therapeutics Inc to make 750k in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at -212.40%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -8.72%.
APLT Dividends
Applied Therapeutics Inc’s next quarterly earnings report is expected to be released in November.
Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 5.31% of Applied Therapeutics Inc shares, and 95.37% of them are in the hands of institutional investors. The stock currently has a share float of 100.72%. Applied Therapeutics Inc stock is held by 130.0 institutions, with FRANKLIN RESOURCES INC being the largest institutional investor. By 2024-06-30, it held 8.1496% of the shares, which is about 10.21 million shares worth $47.69 million.
VR ADVISER, LLC, with 7.6149% or 9.54 million shares worth $44.57 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
